0001806605-20-000001.txt : 20200313 0001806605-20-000001.hdr.sgml : 20200313 20200313143924 ACCESSION NUMBER: 0001806605-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200313 DATE AS OF CHANGE: 20200313 EFFECTIVENESS DATE: 20200313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medexus Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001806605 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-362803 FILM NUMBER: 20712051 BUSINESS ADDRESS: STREET 1: 225 - 1 PLACE DU COMMERCE CITY: VERDUN STATE: A8 ZIP: H3E 1A2 BUSINESS PHONE: 514 762-2626 MAIL ADDRESS: STREET 1: 225 - 1 PLACE DU COMMERCE CITY: VERDUN STATE: A8 ZIP: H3E 1A2 D 1 primary_doc.xml X0708 D LIVE 0001806605 Medexus Pharmaceuticals Inc. 225 - 1 PLACE DU COMMERCE VERDUN A8 QUEBEC, CANADA H3E 1A2 514 762-2626 CANADA (FEDERAL LEVEL) Pediapharm Inc. Chelsea Acqusition Corp. None Corporation true Ken d'Entremont 225 - 1 Place du Commerce Verdun A8 QUEBEC, CANADA H3E 1A2 Executive Officer Director Roland Boivin 225 - 1 Place du Commerce Verdun A8 QUEBEC, CANADA H3E 1A2 Executive Officer Terri Shoemaker 225 - 1 Place du Commerce Verdun A8 QUEBEC, CANADA H3E 1A2 Executive Officer Peter van der Velden 225 - 1 Place du Commerce Verdun A8 QUEBEC, CANADA H3E 1A2 Director Michael Mueller 225 - 1 Place du Commerce Verdun A8 QUEBEC, CANADA H3E 1A2 Director Benoit Gravel 225 - 1 Place du Commerce Verdun A8 QUEBEC, CANADA H3E 1A2 Director Stephen Nelson 225 - 1 Place du Commerce Verdun A8 QUEBEC, CANADA H3E 1A2 Director Adele Gulfo 225 - 1 Place du Commerce Verdun A8 QUEBEC, CANADA H3E 1A2 Director Pharmaceuticals $25,000,001 - $100,000,000 06b false 2020-02-28 true true true true true Each Warrant entitles its holders to purchase 1 common share ("CS") at Cdn$4.00 per CS until the earlier of (a) 2/1/2024 and (b) the date that is 91 days prior to the maturity of the 2023 convertible notes unless such notes have been converted into CS. false 0 400000 400000 0 The additional $400,000 may be received upon the exercise of share purchase warrants sold inside or outside the U.S. U.S. dollars amounts are based on the Bank of Canada average rate of exchange reported on 2/28/2020, which was Cdn$1.3429=USD$1.00. false 1 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Medexus Pharmaceuticals Inc. Roland Boivin Roland Boivin Chief Financial Officer 2020-03-10